Rapid risk assessment: Public health risks related to communicable diseases during the 2018 Hajj, Saudi Arabia, 19–24 August 2018
The aim of this document is to assess the potential health risks related to communicable diseases and other health threats for EU/EEA citizens during their stay in Saudi Arabia for the Hajj pilgrimage between 19 and 24 August 2018.
Due to the vaccination requirements for travelling to Mecca, Saudi Arabia, and the preparedness plans put in place by the host country addressing the management of health hazards during and after the Hajj, the overall risk for EU/EEA citizens of becoming infected with a contagious disease during the 2018 Hajj in Saudi Arabia is considered to be low. The risk of communicable disease outbreaks is highest for food- and waterborne diseases and respiratory illnesses, but the risk is not considered higher than can generally be expected for international mass gatherings of this size. MERS-CoV activity continues to be reported in the Arabian Peninsula, specifically from Saudi Arabia, and therefore imported cases may be detected in Europe following the Hajj. The risk of transmission of other vaccine-preventable and vector-borne diseases is considered to be low. The national health authorities in countries from where Muslims embark on the Hajj pilgrimage to Mecca should apply appropriate strategies for the prevention and control of communicable diseases before, during and after the completion of the Hajj.
Latest risk assessments
Rapid risk assessment: Ebola virus disease outbreak in North Kivu and Ituri Provinces, Democratic Republic of the Congo – second update
21 Dec 2018 - This is the second update of a rapid risk assessment originally produced on 9 August 2018. This rapid risk assessment addresses the public health risk associated with the current EVD outbreak in the DRC and its implications for EU/EEA citizens.
Rapid risk assessment: Influenza-associated invasive pulmonary aspergillosis, Europe
30 Nov 2018 - This report assesses the risk of invasive pulmonary aspergillosis (IPA) among patients with severe influenza in hospital intensive care units in the European Union (EU)/European Economic Area (EEA)
Rapid risk assessment: Multidrug-resistant Staphylococcus epidermidis
8 Nov 2018 - This rapid risk assessment addresses the public health risk associated with a previously unrecognised international spread of near pandrug-resistant strains of S. epidermidis as a cause of infection in several countries including EU Member States.